Organization type


  • Contract research organization (CRO)

Early phases


  • Biomarker identification
  • Target identification – new biological hypothesis
  • Target validation – Hypothesis verification

Screening


  • Assay development
    • In vivo screening models
  • Chemical libraries
    • Functional genomics libraries
    • Natural product extracts: plants, microbial, animal (invertebrates, insects)
    • Small molecules (including natural product, DNA encoded libraries and fragment libraries)
  • Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)

Optimization phases


  • In vivo animal models (including assay/model development and testing)
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • Safety
    • Toxicology

Terapeutic areas


  • Autoimmunity / Inflammation
  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Ophthalmology / Optometry
  • Rare diseases

Additional activities


  • CROs providing no-regulatory and regulatory services for drug discovery